Xvivo Perfusion AB (XVIPF)
25.48
-5.47
(-17.67%)
USD |
OTCM |
Sep 17, 16:00
Xvivo Perfusion Price to Book Value : 3.530 for Sept. 17, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 17, 2026 | 3.530 |
| September 16, 2026 | 4.288 |
| September 15, 2026 | 4.288 |
| September 14, 2026 | 4.288 |
| September 11, 2026 | 4.288 |
| September 10, 2026 | 4.288 |
| September 09, 2026 | 4.288 |
| September 08, 2026 | 4.288 |
| September 04, 2026 | 4.288 |
| September 03, 2026 | 4.288 |
| September 02, 2026 | 4.288 |
| September 01, 2026 | 4.288 |
| August 31, 2026 | 4.288 |
| August 28, 2026 | 4.288 |
| August 27, 2026 | 4.288 |
| August 26, 2026 | 4.288 |
| August 25, 2026 | 4.288 |
| August 24, 2026 | 4.288 |
| August 21, 2026 | 4.288 |
| August 20, 2026 | 4.288 |
| August 19, 2026 | 4.288 |
| August 18, 2026 | 4.288 |
| August 17, 2026 | 4.288 |
| August 14, 2026 | 4.157 |
| August 13, 2026 | 4.157 |
| Date | Value |
|---|---|
| August 12, 2026 | 4.157 |
| August 11, 2026 | 4.157 |
| August 10, 2026 | 4.157 |
| August 07, 2026 | 3.395 |
| August 06, 2026 | 3.395 |
| August 05, 2026 | 3.395 |
| August 04, 2026 | 3.395 |
| August 03, 2026 | 3.395 |
| July 31, 2026 | 3.395 |
| July 30, 2026 | 3.395 |
| July 29, 2026 | 3.395 |
| July 28, 2026 | 3.395 |
| July 27, 2026 | 3.395 |
| July 24, 2026 | 3.395 |
| July 23, 2026 | 3.395 |
| July 22, 2026 | 3.395 |
| July 21, 2026 | 3.395 |
| July 20, 2026 | 3.612 |
| July 17, 2026 | 3.612 |
| July 16, 2026 | 3.612 |
| July 15, 2026 | 4.085 |
| July 14, 2026 | 4.085 |
| July 13, 2026 | 4.085 |
| July 10, 2026 | 4.085 |
| July 09, 2026 | 4.085 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Getinge AB | 2.065 |
| Paxman AB | 1.891 |
| Enovis Corp. | 0.6879 |
| Edwards Lifesciences Corp. | 4.787 |
| Intuitive Surgical, Inc. | 7.645 |
Price to Book Value Related Metrics
| PE Ratio | 84.34 |
| PS Ratio | 8.391 |
| Price to Free Cash Flow | 31.94 |
| Price | 25.48 |
| Earnings Yield | 1.19% |
| Market Cap | 802.61M |
| Operating PE Ratio | 68.98 |
| Normalized PE Ratio | 84.54 |